• Lonza Opens Innovation Center in Israel contractpharma
    November 28, 2018
    Lonza Pharma & Biotech has opened its Collaborative Innovation Center (CIC) in the Haifa Life Science Park, Israel. The CIC acts as a hub for partnerships that aim to identify
  • CRISPR, ViaCyte team up to develop stem cell therapies for diabetes pharmaceutical-technology
    September 20, 2018
    Swiss gene editing company CRISPR Therapeutics and US-based regenerative medicine firm ViaCyte have formed a strategic alliance to discover, develop and commercialise stem cell therapies for diabetes patients.
  • CGT Catapult unveils major UK investment in skills and capabilities pharmatimes
    July 06, 2018
    The Cell and Gene Therapy Catapult (CGT Catapult) has announced a major investment in skills and capability training to help accelerate integration of cell and gene therapies into health services following their regulatory approval.
PharmaSources Customer Service